173 related articles for article (PubMed ID: 34706772)
1. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
[TBL] [Abstract][Full Text] [Related]
2. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
4. Risk of malignancy in Korean patients with primary Sjögren's syndrome.
Kang J; Kim H; Kim J; Choi S; Jung SY; Jang EJ; Cho SK; Sung YK
Int J Rheum Dis; 2020 Aug; 23(9):1240-1247. PubMed ID: 32841507
[TBL] [Abstract][Full Text] [Related]
5. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
[TBL] [Abstract][Full Text] [Related]
7. Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study.
Chung MK; Park JS; Lim H; Lee CH; Lee J
Lupus; 2021 Apr; 30(4):674-679. PubMed ID: 33460342
[TBL] [Abstract][Full Text] [Related]
8. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of malignancy in patients with Takayasu's arteritis: a population-based cohort study in Korea.
Lee S; Kang S; Eun Y; Kim H; Lee J; Koh EM; Cha HS
Sci Rep; 2022 Dec; 12(1):22047. PubMed ID: 36543807
[TBL] [Abstract][Full Text] [Related]
10. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
11. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.
Choi HS; Han KD; Jung JH; Kim CS; Bae EH; Ma SK; Kim SW
Medicine (Baltimore); 2019 Jul; 98(28):e16420. PubMed ID: 31305460
[TBL] [Abstract][Full Text] [Related]
12. Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study.
Han JY; Cho SK; Kim H; Jeon Y; Kang G; Jung SY; Jang EJ; Sung YK
Sci Rep; 2024 Jan; 14(1):1082. PubMed ID: 38212487
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus and malignancies risk.
Mao S; Shen H; Zhang J
J Cancer Res Clin Oncol; 2016 Jan; 142(1):253-62. PubMed ID: 26319223
[TBL] [Abstract][Full Text] [Related]
14. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cancer among female patients with systemic lupus erythematosus in Korea.
Kang KY; Kim HO; Yoon HS; Lee J; Lee WC; Ko HJ; Ju JH; Cho CS; Kim HY; Park SH
Clin Rheumatol; 2010 Apr; 29(4):381-8. PubMed ID: 20041274
[TBL] [Abstract][Full Text] [Related]
16. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
17. Systemic lupus erythematosus is a risk factor for cancer: a nationwide population-based study in Korea.
Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim CS; Ma SK; Kim SW
Lupus; 2019 Mar; 28(3):317-323. PubMed ID: 30712493
[TBL] [Abstract][Full Text] [Related]
18. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
19. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
20. Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study.
Bae EH; Lim SY; Han KD; Jung JH; Choi HS; Kim HY; Kim CS; Ma SK; Kim SW
Korean J Intern Med; 2020 May; 35(3):652-661. PubMed ID: 31212409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
